CONMED CORPORATION Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax
CONMED CORPORATION (CNMD) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax of $176.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax · last filed 2026-07-29
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, tax for the quarter ending 2026-06-30 was $176.00K.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, tax for the quarter ending 2025-12-31 was $10.00K, a 97.68% decline year-over-year.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, tax for the quarter ending 2025-09-30 was -$131.00K, a 301.54% decline year-over-year.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, tax for the quarter ending 2025-06-30 was -$218.00K, a 145.51% decline year-over-year.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, tax for fiscal 2025 was -$57.00K, a 104.35% decline from fiscal 2024.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, tax for fiscal 2024 was $1.31M, a 37.33% decline from fiscal 2023.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, tax for fiscal 2023 was $2.09M, a 46.14% decline from fiscal 2022.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, tax for fiscal 2022 was $3.88M.
| Period end | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax 3 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax 6 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax 9 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $176.00K 10-Q · filed 2026-07-29 | $157.00K 10-Q · filed 2026-07-29 | ||
| 2025-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$121.00K derived: sum of 2 quarters · filed 2026-02-17 | -$339.00K derived: sum of 3 quarters · filed 2026-07-29 | -$57.00K 10-K · filed 2026-02-17 |
| 2025-09-30 | -$131.00K 10-Q · filed 2025-11-06 | -$349.00K derived: sum of 2 quarters · filed 2026-07-29 | -$67.00K 10-Q · filed 2025-11-06 | $364.00K derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | -$218.00K 10-Q · filed 2026-07-29 | $64.00K 10-Q · filed 2026-07-29 | $495.00K derived: sum of 3 quarters · filed 2026-07-29 | $560.00K derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $282.00K 10-Q · filed 2025-05-01 | $713.00K derived: sum of 2 quarters · filed 2026-02-17 | $778.00K derived: sum of 3 quarters · filed 2026-02-17 | $1.26M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-12-31 | $431.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $496.00K derived: sum of 2 quarters · filed 2026-02-17 | $975.00K derived: sum of 3 quarters · filed 2026-02-17 | $1.31M 10-K · filed 2026-02-17 |
| 2024-09-30 | $65.00K 10-Q · filed 2025-11-06 | $544.00K derived: sum of 2 quarters · filed 2025-11-06 | $880.00K 10-Q · filed 2025-11-06 | $1.51M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $479.00K 10-Q · filed 2025-07-31 | $815.00K 10-Q · filed 2025-07-31 | $1.44M derived: sum of 3 quarters · filed 2026-02-17 | $2.07M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $336.00K 10-Q · filed 2025-05-01 | $962.00K derived: sum of 2 quarters · filed 2026-02-17 | $1.59M derived: sum of 3 quarters · filed 2026-02-17 | $2.09M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $626.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $1.25M derived: sum of 2 quarters · filed 2026-02-17 | $1.76M derived: sum of 3 quarters · filed 2026-02-17 | $2.09M 10-K · filed 2026-02-17 |
| 2023-09-30 | $625.00K 10-Q · filed 2024-10-31 | $1.13M derived: sum of 2 quarters · filed 2024-10-31 | $1.47M 10-Q · filed 2024-10-31 | $2.75M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $507.00K 10-Q · filed 2024-08-01 | $842.00K 10-Q · filed 2024-08-01 | $2.12M derived: sum of 3 quarters · filed 2025-02-18 | $3.41M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $335.00K 10-Q · filed 2024-04-25 | $1.62M derived: sum of 2 quarters · filed 2025-02-18 | $2.90M derived: sum of 3 quarters · filed 2025-02-18 | $3.78M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $2.57M derived: sum of 2 quarters · filed 2025-02-18 | $3.44M derived: sum of 3 quarters · filed 2025-02-18 | $3.88M 10-K · filed 2025-02-18 |
| 2022-09-30 | $1.29M 10-Q · filed 2023-10-26 | $2.16M derived: sum of 2 quarters · filed 2023-10-26 | $2.60M 10-Q · filed 2023-10-26 | $2.56M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $873.00K 10-Q · filed 2023-07-27 | $1.31M 10-Q · filed 2023-07-27 | $1.28M derived: sum of 3 quarters · filed 2024-02-28 | $1.12M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $441.00K 10-Q · filed 2023-04-27 | $403.00K derived: sum of 2 quarters · filed 2024-02-28 | $244.00K derived: sum of 3 quarters · filed 2024-02-28 | -$145.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$197.00K derived: sum of 2 quarters · filed 2024-02-28 | -$586.00K derived: sum of 3 quarters · filed 2024-02-28 | -$969.00K 10-K · filed 2024-02-28 |
| 2021-09-30 | -$159.00K 10-Q · filed 2022-10-27 | -$548.00K derived: sum of 2 quarters · filed 2022-10-27 | -$931.00K 10-Q · filed 2022-10-27 | -$960.00K derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | -$389.00K 10-Q · filed 2022-07-28 | -$772.00K 10-Q · filed 2022-07-28 | -$801.00K derived: sum of 3 quarters · filed 2023-02-21 | -$693.00K derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | -$383.00K 10-Q · filed 2022-05-05 | -$412.00K derived: sum of 2 quarters · filed 2023-02-21 | -$304.00K derived: sum of 3 quarters · filed 2023-02-21 | -$322.00K derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | -$29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $79.00K derived: sum of 2 quarters · filed 2023-02-21 | $61.00K derived: sum of 3 quarters · filed 2023-02-21 | $333.00K 10-K · filed 2023-02-21 |
| 2020-09-30 | $108.00K 10-Q · filed 2021-10-28 | $90.00K derived: sum of 2 quarters · filed 2021-10-28 | $362.00K 10-Q · filed 2021-10-28 | $945.00K derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | -$18.00K 10-Q · filed 2021-07-29 | $254.00K 10-Q · filed 2021-07-29 | $837.00K derived: sum of 3 quarters · filed 2022-02-22 | $1.41M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $272.00K 10-Q · filed 2021-04-29 | $855.00K derived: sum of 2 quarters · filed 2022-02-22 | $1.43M derived: sum of 3 quarters · filed 2022-02-22 | $1.97M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $583.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $1.15M derived: sum of 2 quarters · filed 2022-02-22 | $1.69M derived: sum of 3 quarters · filed 2022-02-22 | $2.08M 10-K · filed 2022-02-22 |
| 2019-09-30 | $570.00K 10-Q · filed 2020-10-29 | $1.11M derived: sum of 2 quarters · filed 2020-10-29 | $1.50M 10-Q · filed 2020-10-29 | |
| 2019-06-30 | $540.00K 10-Q · filed 2020-07-30 | $926.00K 10-Q · filed 2020-07-30 | ||
| 2019-03-31 | $386.00K 10-Q · filed 2020-04-30 | |||
| 2018-12-31 | -$221.00K 10-K · filed 2021-02-22 | |||
| 2017-12-31 | -$265.00K 10-K · filed 2020-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |